Analyst Ratings For AbbVie (NYSE:ABBV)
Today, Credit Suisse Group reiterated its Neutral rating on AbbVie (NYSE:ABBV) with a price target of $74.00.
There are 7 hold ratings, 5 buy ratings, 1 strong buy rating on the stock.
The current consensus rating on AbbVie (NYSE:ABBV) is Buy (Score: 2.54) with a consensus target price of $74.58 per share, a potential 2.49% upside.
Some recent analyst ratings include
- 7/20/2017-Credit Suisse Group Reiterated Rating of Neutral.
- 7/17/2017-Deutsche Bank AG Reiterated Rating of Hold.
- 7/17/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 6/22/2017-Leerink Swann Reiterated Rating of Market Perform.
- 6/22/2017-Societe Generale Upgrade from a “Hold ” rating to a ” Buy” rating.
- 5/17/2017-BMO Capital Markets Reiterated Rating of Market Perform.
- 3/11/2017-Goldman Sachs Group, Inc. (The) Upgrade from a “Buy ” rating to a ” Conviction-Buy” rating.
Dividend information for AbbVie (NYSE:ABBV)
AbbVie (NYSE:ABBV) pays an annual dividend of Community Ranking: with a yield of 3.52% and an average dividend growth of 12.50% based on a 3 Year Average.
Dividend History for AbbVie (NYSE:ABBV)
- On 6/23/2017 AbbVie announced a quarterly dividend of $0.64 3.52% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
- On 2/17/2017 AbbVie announced a quarterly dividend of $0.64 4.14% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
- On 10/28/2016 AbbVie announced a quarterly dividend of $0.64 4.44% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
- On 9/12/2016 AbbVie announced a quarterly dividend of $0.57 3.56% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.
- On 6/17/2016 AbbVie announced a quarterly dividend of $0.57 3.8% with an ex dividend date of 7/13/2016 which will be payable on 8/15/2016.
- On 2/19/2016 AbbVie announced a quarterly dividend of $0.57 4.2% with an ex dividend date of 4/13/2016 which will be payable on 5/16/2016.
- On 11/2/2015 AbbVie announced a quarterly dividend of $0.57 3.6% with an ex dividend date of 1/13/2016 which will be payable on 2/16/2016.
Recent Insider Trading Activity For AbbVie (NYSE:ABBV)
AbbVie (NYSE:ABBV) has insider ownership of 0.23% and institutional ownership of 68.04%.
- On 6/14/2017 Carlos Alban, EVP, sold 45,800 with an average share price of $70.00 per share and the total transaction amounting to $3,206,000.00. View SEC Filing
- On 6/14/2017 Laura J Schumacher, Insider, sold 79,800 with an average share price of $70.00 per share and the total transaction amounting to $5,586,000.00. View SEC Filing
- On 5/19/2017 Richard A Gonzalez, Chairman, sold 71,235 with an average share price of $65.49 per share and the total transaction amounting to $4,665,180.15. View SEC Filing
- On 5/18/2017 William J Chase, CFO, sold 38,300 with an average share price of $65.35 per share and the total transaction amounting to $2,502,905.00. View SEC Filing
- On 5/4/2017 Carlos Alban, EVP, sold 43,000 with an average share price of $67.00 per share and the total transaction amounting to $2,881,000.00. View SEC Filing
- On 3/10/2017 Laura J Schumacher, Insider, sold 40,000 with an average share price of $65.26 per share and the total transaction amounting to $2,610,400.00. View SEC Filing
- On 3/10/2017 Robert A Michael, VP, sold 5,132 with an average share price of $65.29 per share and the total transaction amounting to $335,068.28. View SEC Filing
Recent Trading Activity for AbbVie (NYSE:ABBV)
Shares of AbbVie closed the previous trading session at 72.77 up +0.49 0.68% with 3,904,137 shares trading hands.